Congenital Adrenal Hyperplasia

Area of Science:

• Pediatric Endocrinology
• Genetics
• Metabolic Disorders

Background:

• Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disorder.
• It results in impaired cortisol and often aldosterone production.
• CAH requires lifelong hormone replacement therapy.

Purpose of the Study:

• To summarize the clinical presentation of CAH in infants.
• To highlight the importance of understanding CAH diagnosis and management.
• To emphasize the need for timely intervention to optimize pediatric outcomes.

Main Methods:

• Review of clinical manifestations in affected infants.
• Discussion of diagnostic approaches including newborn screening.
• Overview of current treatment strategies for CAH.

Main Results:

• Female infants often present at birth with virilized genitalia.
• Male infants may be diagnosed via newborn screening or during adrenal crisis.
• CAH diagnosis necessitates lifelong hormone management.

Conclusions:

• Recognizing the diverse presentations of CAH is crucial for early diagnosis.
• Effective management of CAH is essential for preventing adrenal crisis and ensuring healthy development.
• Understanding CAH is critical for pediatric healthcare providers to optimize patient outcomes.